Cargando…
The current use of glaucoma virtual clinics in Europe
OBJECTIVES: To assess and describe current utilisation, characteristics and perspectives on virtual glaucoma clinics (VGCs) amongst European glaucoma specialists. METHODS: Cross-sectional, anonymized, online questionnaire distributed to all European Glaucoma Society-registered specialists. Questions...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188015/ https://www.ncbi.nlm.nih.gov/pubmed/35690678 http://dx.doi.org/10.1038/s41433-022-02111-5 |
_version_ | 1784725283418406912 |
---|---|
author | Azzopardi, Matthew Prokosch-Willing, Verena Michelessi, Manuele Fea, Antonio Maria Oddone, Francesco Mercieca, Karl |
author_facet | Azzopardi, Matthew Prokosch-Willing, Verena Michelessi, Manuele Fea, Antonio Maria Oddone, Francesco Mercieca, Karl |
author_sort | Azzopardi, Matthew |
collection | PubMed |
description | OBJECTIVES: To assess and describe current utilisation, characteristics and perspectives on virtual glaucoma clinics (VGCs) amongst European glaucoma specialists. METHODS: Cross-sectional, anonymized, online questionnaire distributed to all European Glaucoma Society-registered specialists. Questions were stratified into five domains: Demographics, Questions about VGC use, Questions for non-VGC users, COVID-19 effects, and VGC advantages/disadvantages. RESULTS: 30% of 169 participants currently use VGCs, with 53% based in the United Kingdom. Of those using VGCs, 85% reported higher patient acceptance compared to traditional care. The commonest virtual model was asynchronous remote monitoring (54%). Nurses (49%) and ophthalmic technicians (46%) were mostly responsible for data collection, with two-thirds using a mixture of professionals. Consultant ophthalmologists were the main decision-makers in 51% of VGCs. Preferred cohorts were: ocular hypertension (85%), glaucoma suspects (80%), early/moderate glaucoma in worse eye (68%), stable glaucoma irrespective of treatment (59%) and stable glaucoma on monotherapy (51%). Commonest investigations were: IOP (90%), BCVA (88%), visual field testing (85%) and OCT (78%), with 33 different combinations. Reasons for face-to-face referral included: visual field progression (80%), ‘above-target’ IOP (63%), and OCT progression (51%). Reasons for not using VGCs included: lack of experience (47%), adequate systems in place (42%), no appropriate staff (34%) and insufficient time/money (34%). 55% of non-VGC users are interested in their use with 38% currently considering future implementation. 83% stated VGC consultations have increased during the COVID-19 pandemic; 86% of all participants felt that the pandemic has highlighted the importance of VGCs. CONCLUSIONS: A significant proportion of European glaucoma units are currently using VGCs, while others are considering implementation. Financial reimbursement and consensus guidelines are potentially crucial steps in VGC uptake. |
format | Online Article Text |
id | pubmed-9188015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91880152022-06-17 The current use of glaucoma virtual clinics in Europe Azzopardi, Matthew Prokosch-Willing, Verena Michelessi, Manuele Fea, Antonio Maria Oddone, Francesco Mercieca, Karl Eye (Lond) Article OBJECTIVES: To assess and describe current utilisation, characteristics and perspectives on virtual glaucoma clinics (VGCs) amongst European glaucoma specialists. METHODS: Cross-sectional, anonymized, online questionnaire distributed to all European Glaucoma Society-registered specialists. Questions were stratified into five domains: Demographics, Questions about VGC use, Questions for non-VGC users, COVID-19 effects, and VGC advantages/disadvantages. RESULTS: 30% of 169 participants currently use VGCs, with 53% based in the United Kingdom. Of those using VGCs, 85% reported higher patient acceptance compared to traditional care. The commonest virtual model was asynchronous remote monitoring (54%). Nurses (49%) and ophthalmic technicians (46%) were mostly responsible for data collection, with two-thirds using a mixture of professionals. Consultant ophthalmologists were the main decision-makers in 51% of VGCs. Preferred cohorts were: ocular hypertension (85%), glaucoma suspects (80%), early/moderate glaucoma in worse eye (68%), stable glaucoma irrespective of treatment (59%) and stable glaucoma on monotherapy (51%). Commonest investigations were: IOP (90%), BCVA (88%), visual field testing (85%) and OCT (78%), with 33 different combinations. Reasons for face-to-face referral included: visual field progression (80%), ‘above-target’ IOP (63%), and OCT progression (51%). Reasons for not using VGCs included: lack of experience (47%), adequate systems in place (42%), no appropriate staff (34%) and insufficient time/money (34%). 55% of non-VGC users are interested in their use with 38% currently considering future implementation. 83% stated VGC consultations have increased during the COVID-19 pandemic; 86% of all participants felt that the pandemic has highlighted the importance of VGCs. CONCLUSIONS: A significant proportion of European glaucoma units are currently using VGCs, while others are considering implementation. Financial reimbursement and consensus guidelines are potentially crucial steps in VGC uptake. Nature Publishing Group UK 2022-06-11 2023-05 /pmc/articles/PMC9188015/ /pubmed/35690678 http://dx.doi.org/10.1038/s41433-022-02111-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Azzopardi, Matthew Prokosch-Willing, Verena Michelessi, Manuele Fea, Antonio Maria Oddone, Francesco Mercieca, Karl The current use of glaucoma virtual clinics in Europe |
title | The current use of glaucoma virtual clinics in Europe |
title_full | The current use of glaucoma virtual clinics in Europe |
title_fullStr | The current use of glaucoma virtual clinics in Europe |
title_full_unstemmed | The current use of glaucoma virtual clinics in Europe |
title_short | The current use of glaucoma virtual clinics in Europe |
title_sort | current use of glaucoma virtual clinics in europe |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188015/ https://www.ncbi.nlm.nih.gov/pubmed/35690678 http://dx.doi.org/10.1038/s41433-022-02111-5 |
work_keys_str_mv | AT azzopardimatthew thecurrentuseofglaucomavirtualclinicsineurope AT prokoschwillingverena thecurrentuseofglaucomavirtualclinicsineurope AT michelessimanuele thecurrentuseofglaucomavirtualclinicsineurope AT feaantoniomaria thecurrentuseofglaucomavirtualclinicsineurope AT oddonefrancesco thecurrentuseofglaucomavirtualclinicsineurope AT merciecakarl thecurrentuseofglaucomavirtualclinicsineurope AT azzopardimatthew currentuseofglaucomavirtualclinicsineurope AT prokoschwillingverena currentuseofglaucomavirtualclinicsineurope AT michelessimanuele currentuseofglaucomavirtualclinicsineurope AT feaantoniomaria currentuseofglaucomavirtualclinicsineurope AT oddonefrancesco currentuseofglaucomavirtualclinicsineurope AT merciecakarl currentuseofglaucomavirtualclinicsineurope |